Inhibitory Antibodies
-
F1981 Anti-ERBB1/EGFR/HER1 Antibody (Shanghai Cancer Inst patent anti-EGFRvIII)Summary: Anti-ERBB1/EGFR/HER1 Antibody (Shanghai Cancer Inst patent anti-EGFRvIII) -
F1982 Anti-ERBB2/HER2/CD340 Antibody (BioMab patent anti-Her2)Summary: Anti-ERBB2/HER2/CD340 Antibody (BioMab patent anti-Her2) -
F1983 Anti-ERBB3/ HER3 Antibody (Patritumab-MMAE)Summary: Anti-ERBB3/ HER3 Antibody (Patritumab-MMAE) -
F1984 Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Chugai patent anti-TF)Summary: Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Chugai patent anti-TF) -
F1985 Anti-Fc gamma R1 Antibody (Medarex Patent Anti-Fc-Gamma-R1)Summary: Anti-Fc gamma R1 Antibody (Medarex Patent Anti-Fc-Gamma-R1) -
F1986 Anti-FOLH1/PSMA Antibody (Rosopatamab tetraxetan)Summary: Anti-FOLH1/PSMA Antibody (Rosopatamab tetraxetan) -
F1987 Anti-FOLH1/PSMA Antibody (Rosopatamab-MMAE)Summary: Anti-FOLH1/PSMA Antibody (Rosopatamab-MMAE) -
F1988 Anti-FOLR1/FRA Antibody (Mirvetuximab soravtansine)Summary: Anti-FOLR1/FRA Antibody (Mirvetuximab soravtansine) -
F1989 Anti-FOLR1/FRA Antibody (Dompe patent anti-FOLR1)Summary: Anti-FOLR1/FRA Antibody (Dompe patent anti-FOLR1) -
F1990 Anti-FZD7 Antibody (U.Toronto patent anti-FZD7)Summary: Anti-FZD7 Antibody (U.Toronto patent anti-FZD7)